Ibrance® (palbociclib) approved for ER+, HER2- advanced breast cancer, available immediately at Biologics, Inc.
CARY, NC — February 5, 2015 — Biologics, an integrated oncology services company, is pleased to announce that Biologics has been […]
CARY, NC — February 5, 2015 — Biologics, an integrated oncology services company, is pleased to announce that Biologics has been […]